Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Anticoagulation-related intracranial hemorrhages.

Mittal MK, Rabinstein AA.

Curr Atheroscler Rep. 2012 Aug;14(4):351-9. doi: 10.1007/s11883-012-0258-8. Review.

PMID:
22638877
2.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
3.

Reversal of direct oral anticoagulants.

Zhang XY, Desborough MJ, Shapiro S.

Br J Hosp Med (Lond). 2017 Mar 2;78(3):165-169. doi: 10.12968/hmed.2017.78.3.165. Review.

PMID:
28277769
4.

Intracranial bleedings in patients on long-term anticoagulant treatment: Benefits from oral thrombin and factor Xa inhibitors in clinical practice.

Łukasik M, Zawilska K, Undas A.

Neurol Neurochir Pol. 2015;49(3):171-9. doi: 10.1016/j.pjnns.2015.04.007. Epub 2015 May 7. Review.

PMID:
26048605
5.

Current state of knowledge on oral anticoagulant reversal using procoagulant factors.

Nitzki-George D, Wozniak I, Caprini JA.

Ann Pharmacother. 2013 Jun;47(6):841-55. doi: 10.1345/aph.1R724. Epub 2013 May 21. Review.

PMID:
23695644
6.

Management of intracranial bleeding in anticoagulated patients.

Thompson A.

Br J Hosp Med (Lond). 2009 Jun;70(6):336-8. Review.

PMID:
19516210
7.

Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, del Zoppo GJ, Kumar MA, Peerschke EI, Stiefel MF, Teitelbaum JS, Wartenberg KE, Zerfoss CL.

Neurocrit Care. 2016 Feb;24(1):6-46. doi: 10.1007/s12028-015-0222-x. Review.

PMID:
26714677
8.

A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.

Kumar R, Smith RE, Henry BL.

J Intensive Care Med. 2015 Dec;30(8):462-72. doi: 10.1177/0885066614527417. Epub 2014 Mar 25. Review.

PMID:
24668159
9.

New oral anticoagulants for atrial fibrillation: a review of clinical trials.

O'Dell KM, Igawa D, Hsin J.

Clin Ther. 2012 Apr;34(4):894-901. doi: 10.1016/j.clinthera.2012.01.019. Epub 2012 Mar 13. Review.

PMID:
22417716
10.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
11.

Old and new anticoagulant drugs: a minireview.

Mannucci PM, Franchini M.

Ann Med. 2011 Mar;43(2):116-23. doi: 10.3109/07853890.2010.539250. Epub 2011 Jan 24. Review.

PMID:
21254900
12.

Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature.

Bershad EM, Suarez JI.

Neurocrit Care. 2010 Jun;12(3):403-13. doi: 10.1007/s12028-009-9310-0. Review.

PMID:
19967567
13.

The use of vitamin K in patients on anticoagulant therapy: a practical guide.

Hanslik T, Prinseau J.

Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.

PMID:
14967065
14.

New anticoagulants: focus on venous thromboembolism.

Gómez-Outes A, Lecumberri R, Pozo C, Rocha E.

Curr Vasc Pharmacol. 2009 Jul;7(3):309-29. Review.

PMID:
19601856
15.

Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?

Fareed J, Iqbal O, Cunanan J, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Int Angiol. 2008 Jun;27(3):176-92. Review.

PMID:
18506123
16.

Controversies of anticoagulation reversal in life-threatening bleeds.

Rolfe S, Papadopoulos S, Cabral KP.

J Pharm Pract. 2010 Jun;23(3):217-25. doi: 10.1177/0897190010362168. Epub 2010 Apr 13. Review.

PMID:
21507817
17.

New anticoagulants for the prevention of stroke in atrial fibrillation.

Höchtl T, Huber K.

Fundam Clin Pharmacol. 2012 Feb;26(1):47-53. doi: 10.1111/j.1472-8206.2011.00982.x. Epub 2011 Aug 29. Review.

PMID:
21883447
18.

Survival of heparins, oral anticoagulants, and aspirin after the year 2010.

Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.

Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025. Review.

PMID:
18393143
19.

The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

Mavrakanas T, Bounameaux H.

Pharmacol Ther. 2011 Apr;130(1):46-58. doi: 10.1016/j.pharmthera.2010.12.007. Epub 2010 Dec 24. Review.

PMID:
21185864
20.

Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

Garwood CL, Corbett TL.

Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Epub 2008 Mar 11. Review.

PMID:
18334606

Supplemental Content

Support Center